Reperfusion-triggered stress protein response in the myocardium is blocked by post-conditioning. Systems biology pathway analysis highlights the key role of the canonical aryl-hydrocarbon receptor pathway

European Heart Journal

Volumn 34, Issue 27, 2013, Pages 2082-2093

  Vilahur, Gemma ^a   Cubedo, Judit ^a   Casani, Laura ^a   Padro, Teresa ^a   Sabate Tenas, Manel ^d   Badimon, Juan J ^c   Badimon, Lina ^a,b  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d HOSPITAL CLÍNIC   (Spain)

Author keywords

AhR pathway; Cell damage; Ischaemic post conditioning; Proteomics

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; CASPASE 3; CASPASE 8; CYTOPLASM PROTEIN; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 70; MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN BCL 2; PROTEIN KINASE B; PROTEIN P53;

ACUTE HEART INFARCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BALLOON OCCLUSION; CELL DAMAGE; ECHOCARDIOGRAPHY; ENZYME ACTIVATION; EXPERIMENTAL PIG; HEART; HEART FUNCTION; HEART INFARCTION SIZE; HEART INJURY; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PERFORMANCE; HEART PROTECTION; ISCHEMIC POSTCONDITIONING; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; SYSTEMS BIOLOGY; TWO DIMENSIONAL ELECTROPHORESIS;

AHR PATHWAY; CELL DAMAGE; ISCHAEMIC POST-CONDITIONING; PROTEOMICS;

ANIMALS; APOPTOSIS; ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR; CASPASE 8; CORONARY VESSELS; DEOXYURACIL NUCLEOTIDES; ECHOCARDIOGRAPHY; HEAT-SHOCK PROTEINS; ISCHEMIC POSTCONDITIONING; MYOCARDIAL CONTRACTION; MYOCARDIAL REPERFUSION INJURY; PHOSPHATIDYLINOSITOL 3-KINASES; PROTEOME; PROTEOMICS; PROTO-ONCOGENE PROTEINS C-BCL-2; RANDOM ALLOCATION; RECEPTORS, ARYL HYDROCARBON; SIGNAL TRANSDUCTION; SUS SCROFA; SYSTEMS BIOLOGY; TOR SERINE-THREONINE KINASES;

EID: 84872526697     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehs211     Document Type: Article

References (49)

1. Piper HM, Abdallah Y, Schafer C. The first minutes of reperfusion: a window of opportunity for cardioprotection. Cardiovasc Res 2004;61:365-371. (Pubitemid 38210144)
2. Heusch G. Postconditioning: old wine in a new bottle? J Am Coll Cardiol 2004;44: 1111-1112. (Pubitemid 39165148)
3. Vilahur G, Juan-Babot O, Pena E, Onate B, Casani L, Badimon L. Molecular and cellular mechanisms involved in cardiac remodeling after acute myocardial infarction. J Mol Cell Cardiol 2011;50:522-533.
4. Olivetti G, Quaini F, Sala R, Lagrasta C, Corradi D, Bonacina E, Gambert SR, Cigola E, Anversa P. Acute myocardial infarction in humans is associated with activation of programmed myocyte cell death in the surviving portion of the heart. J Mol Cell Cardiol 1996;28:2005-2016. (Pubitemid 26340560)
5. Gottlieb RA, Burleson KO, Kloner RA, Babior BM, Engler RL. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Investig 1994;94:1621-1628. (Pubitemid 24309885)
6. Yellon DM, Alkhulaifi AM, Pugsley WB. Preconditioning the human myocardium. Lancet 1993;342:276-277. (Pubitemid 23224422)
7. Kloner RA, Shook T, Przyklenk K, Davis VG, Junio L, Matthews RV, Burstein S, Gibson M, Poole WK, Cannon CP et al. Previous angina alters in-hospital outcome in timi 4. A clinical correlate to preconditioning? Circulation 1995;91: 37-45.
8. Heusch G. Nitroglycerin and delayed preconditioning in humans: yet another new mechanism for an old drug? Circulation 2001;103:2876-2878. (Pubitemid 32578120)
9. Zhao ZQ, Corvera JS, Halkos ME, Kerendi F, Wang NP, Guyton RA, Vinten-Johansen J. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol 2003;285:H579-H588. (Pubitemid 36885888)
10. Staat P, Rioufol G, Piot C, Cottin Y, Cung TT, L'Huillier I, Aupetit JF, Bonnefoy E, Finet G, Andre-Fouet X, Ovize M. Postconditioning the human heart. Circulation 2005;112:2143-2148. (Pubitemid 41475808)
11. Thibault H, Piot C, Staat P, Bontemps L, Sportouch C, Rioufol G, Cung TT, Bonnefoy E, Angoulvant D, Aupetit JF, Finet G, Andre-Fouet X, Macia JC, Raczka F, Rossi R, Itti R, Kirkorian G, Derumeaux G, Ovize M. Long-term benefit of postconditioning. Circulation 2008;117:1037-1044.
12. Ovize M, Baxter GF, Di Lisa F, Ferdinandy P, Garcia-Dorado D, Hausenloy DJ, Heusch G, Vinten-Johansen J, Yellon DM, Schulz R. Postconditioning and protection from reperfusion injury: where do we stand? Position paper from the working group of cellular biology of the heart of the European society of cardiology. Cardiovasc Res 2010;87:406-423.
13. Heusch G, Boengler K, Schulz R. Inhibition of mitochondrial permeability transition pore opening: the holy grail of cardioprotection. Basic Res Cardiol 2010;105: 151-154.
14. Hausenloy DJ. Signalling pathways in ischaemic postconditioning. Thromb Haemost 2009;101:626-634.
15. Heusch G, Boengler K, Schulz R. Cardioprotection: nitric oxide, protein kinases, and mitochondria. Circulation 2008;118:1915-1919.
16. Schwartz LM, Lagranha CJ. Ischemic postconditioning during reperfusion activates akt and erk without protecting against lethal myocardial ischemia-reperfusion injury in pigs. Am J Physiol Heart Circ Physiol 2006;290:H1011-H1018.
17. Musiolik J, van Caster P, Skyschally A, Boengler K, Gres P, Schulz R, Heusch G. Reduction of infarct size by gentle reperfusion without activation of reperfusion injury salvage kinases in pigs. Cardiovasc Res 2010;85:110-117.
18. Skyschally A, van Caster P, Boengler K, Gres P, Musiolik J, Schilawa D, Schulz R, Heusch G. Ischemic postconditioning in pigs: no causal role for risk activation. Circ Res 2009;104:15-18.
19. Heusch G, Skyschally A, Schulz R. The in-situ pig heart with regional ischemia/reperfusion-ready for translation. J Mol Cell Cardiol 2011;50:951-963.
20. Heusch G, Musiolik J, Gedik N, Skyschally A. Mitochondrial stat3 activation and cardioprotection by ischemic postconditioning in pigs with regional myocardial ischemia/reperfusion. Circ Res 2011;109:1302-1308.
21. Skyschally A, van Caster P, Iliodromitis EK, Schulz R, Kremastinos DT, Heusch G. Ischemic postconditioning: experimental models and protocol algorithms. Basic Res Cardiol 2009;104:469-483.
22. Wagner C, Tillack D, Simonis G, Strasser RH, Weinbrenner C. Ischemic post-conditioning reduces infarct size of the in vivo rat heart: role of pi3-k, mtor, gsk-3beta, and apoptosis. Mol Cell Biochem 2010;339:135-147.
23. Vilahur G, Hernandez-Vera R, Molins B, Casani L, Duran X, Padro T, Badimon L. Short-term myocardial ischemia induces cardiac modified c-reactive protein expression and proinflammatory gene (cyclo-oxygenase-2, monocyte chemoattractant protein-1, and tissue factor) upregulation in peripheral blood mononuclear cells. J Thromb Haemost 2009;7:485-493.
24. Ibanez B, Prat-Gonzalez S, Speidl WS, Vilahur G, Pinero A, Cimmino G, Garcia MJ, Fuster V, Sanz J, Badimon JJ. Early metoprolol administration before coronary reperfusion results in increased myocardial salvage: analysis of ischemic myocardium at risk using cardiac magnetic resonance. Circulation 2007;115:2909-2916. (Pubitemid 46915384)
25. Lundberg KC, Szweda LI. Initiation of mitochondrial-mediated apoptosis during cardiac reperfusion. Arch Biochem Biophys 2004;432:50-57. (Pubitemid 39425028)
26. Padro T, Pena E, Garcia-Arguinzonis M, Llorente-Cortes V, Badimon L. Low-density lipoproteins impair migration of human coronary vascular smooth muscle cells and induce changes in the proteomic profile of myosin light chain. Cardiovasc Res 2008;77:211-220. (Pubitemid 351195161)
27. Cubedo J, Padro T, Garcia-Moll X, Pinto X, Cinca J, Badimon L. Proteomic signature of apolipoprotein j in the early phase of new-onset myocardial infarction. J Proteome Res 2010;10:211-220.
28. Na HS, Kim YI, Yoon YW, Han HC, Nahm SH, Hong SK. Ventricular premature beat-driven intermittent restoration of coronary blood flow reduces the incidence of reperfusion-induced ventricular fibrillation in a cat model of regional ischemia. Am Heart J 1996;132:78-83.
29. Kloner RA, Dow J, Bhandari A. Postconditioning markedly attenuates ventricular arrhythmias after ischemia-reperfusion. J Cardiovasc Pharmacol Ther 2006;11:55-63.
30. Perdew GH. Association of the ah receptor with the 90-kda heat shock protein. J Biol Chem 1988;263:13802-13805.
31. Denis M, Cuthill S, Wikstrom AC, Poellinger L, Gustafsson JA. Association of the dioxin receptor with the mr 90,000 heat shock protein: a structural kinship with the glucocorticoid receptor. Biochem Biophys Res Commun 1988;155:801-807.
32. Pollenz RS, Sattler CA, Poland A. The aryl hydrocarbon receptor and aryl hydrocarbon receptor nuclear translocator protein show distinct subcellular localizations in hepa 1c1c7 cells by immunofluorescence microscopy. Mol Pharmacol 1994;45:428-438. (Pubitemid 24094931)
33. Swanson HI, Bradfield CA. The ah-receptor: genetics, structure and function. Pharmacogenetics 1993;3:213-230. (Pubitemid 23333091)
34. Carver LA, Jackiw V, Bradfield CA. The 90-kda heat shock protein is essential for ah receptor signaling in a yeast expression system. J Biol Chem 1994;269: 30109-30112. (Pubitemid 24376472)
35. Zhang T, Wang X, Shinn A, Jin J, Chan WK. Beta tubulin affects the aryl hydrocarbon receptor function via an arnt-mediated mechanism. Biochem Pharmacol 2010; 79:1125-1133.
36. Matikainen T, Perez GI, Jurisicova A, Pru JK, Schlezinger JJ, Ryu HY, Laine J, Sakai T, Korsmeyer SJ, Casper RF, Sherr DH, Tilly JL. Aromatic hydrocarbon receptor-driven bax gene expression is required for premature ovarian failure caused by biohazardous environmental chemicals. Nat Genet 2001;28:355-360. (Pubitemid 32702425)
37. Park KT, Mitchell KA, Huang G, Elferink CJ. The aryl hydrocarbon receptor predisposes hepatocytes to fas-mediated apoptosis. Mol Pharmacol 2005;67:612-622. (Pubitemid 40365308)
38. Reimer KA, Lowe JE, Rasmussen MM, Jennings RB. The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs. Circulation 1977;56:786-794. (Pubitemid 8235183)
39. DeBoer LW, Rude RE, Kloner RA, Ingwall JS, Maroko PR, Davis MA, Braunwald E. A flow- and time-dependent index of ischemic injury after experimental coronary occlusion and reperfusion. Proc Natl Acad Sci USA 1983;80:5784-5788. (Pubitemid 14249913)
40. Yaoita H, Ogawa K, Maehara K, Maruyama Y. Apoptosis in relevant clinical situations: contribution of apoptosis in myocardial infarction. Cardiovasc Res 2000;45: 630-641. (Pubitemid 30047129)
41. Zhao ZQ, Velez DA, Wang NP, Hewan-Lowe KO, Nakamura M, Guyton RA, Vinten-Johansen J. Progressively developed myocardial apoptotic cell death during late phase of reperfusion. Apoptosis 2001;6:279-290. (Pubitemid 32708522)
42. Piper HM, Garcia-Dorado D, Ovize M. A fresh look at reperfusion injury. Cardiovasc Res 1998;38:291-300. (Pubitemid 28294147)
43. Yaoita H, Ogawa K, Maehara K, Maruyama Y. Attenuation of ischemia/reperfusion injury in rats by a caspase inhibitor. Circulation 1998;97:276-281. (Pubitemid 28067314)
44. Chao WSY, Novikov MS, Li L, Ahn Y, Rosenzweig A. (Abstract). Adenoviral expression of dominant-negative fadd blocks cardiomyocyte apoptosis and reduces myocardial injury after transient ischemia. Circulation 2002;106:II-131.
45. Hausenloy DJ, Baxter G, Bell R, Botker HE, Davidson SM, Downey J, Heusch G, Kitakaze M, Lecour S, Mentzer R, Mocanu MM, Ovize M, Schulz R, Shannon R, Walker M, Walkinshaw G, Yellon DM. Translating novel strategies for cardioprotection: the hatter workshop recommendations. Basic Res Cardiol 2010;105:677-686.
46. Engelhorn T, Schwarz MA, Heusch G, Doerfler A, Schulz R. Reduction of cerebral infarct size by dronedarone. Cardiovasc Drugs Ther 2011;25:523-529.
47. Heusch G. Reduction of infarct size by ischaemic post-conditioning in humans: fact or fiction? Eur Heart J 2012;33:13-15.
48. Freixa X, Bellera N, Ortiz-Perez JT, Jimenez M, Pare C, Bosch X, De Caralt TM, Betriu A, Masotti M. Ischaemic postconditioning revisited: lack of effects on infarct size following primary percutaneous coronary intervention. Eur Heart J 2012;33: 103-112.
49. Schwartz Longacre L, Kloner RA, Arai AE, Baines CP, Bolli R, Braunwald E, Downey J, Gibbons RJ, Gottlieb RA, Heusch G, Jennings RB, Lefer DJ, Mentzer RM, Murphy E, Ovize M, Ping P, Przyklenk K, Sack MN, Vander Heide RS, Vinten-Johansen J, Yellon DM. New horizons in cardioprotection: recommendations from the 2010 national heart, lung, and blood institute workshop. Circulation 2011;124:1172-1179.